1. Food and Drug Administration. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations, 2000. http://www.fda.gov/cder/guidance/3615fnl.pdf.
2. . Bioequivalence and Statistics in Clinical Pharmacology. Chapman & Hall/CRC: New York, 2006.
3. Food and Drug Administration. Statistical Approaches to Establishing Bioequivalence, 2001. http://www.fda.gov/cder/guidance/3616fnl.pdf
4. Health Canada. Report C: Expert Advisory Committee on Bioavailability, 1992. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/bio/biorepc_biorapc_e.html